Status: Currently enrolling
ClinicalTrial.gov Identifier: NCT02980874
CLS1003-301: A Phase 3, randomized, masked, controlled trial to study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunctions with Intravitreal Aflibercept in patients with Retinal Vein Occlusion
Condition: Retinal Vein Occlusion
Study Type: Interventional
Duration: 48 weeks
Eligibility:
For additional information on this study, please click here
Back to Clinical Research